n-Hexane Fraction of Cucumis melo L. Cultivar Gama Melon Parfum: An in vitro Study in MCF7 and T47D Cells Line

Rohmi Salamah, Nastiti Wijayanti, Slamet Widiyanto

Abstract


Background: Cucumis melo a melon species, typically has a sweet taste. Some cultivars are known for their distinctive bitter flesh due to its higher levels of cucurbitacin. Cucurbitacin is semipolar compound that has anticancer properties. However, the anticancer effects of cucurbitacin from gama melon parfum (GMP) have not been widely studied. The use of n-Hexane as a non-polar solvent in GMP melon fractionation is to dissolve the non-polar parts of the plant. However, Cucurbitacin was found in the n-hexane fraction of Cucurbita pepo L. Therefore, this study will investigate the presence of Cucurbitacin in the n-Hexane fraction and its effects on breast cancer cells T47D and MCF7.

Materials and methods: Dry simplicia of GMP melon fruit were macerated using methanol and fractionated using n-hexane. The presence of cucurbitacin was detected using the high-performance liquid chromatography (HPLC) method. Cell cytotoxicity tests were assessed using the MTT assay, with concentrations of 7.8125, 15.625, 31.25, 62.5, and 125 µg/mL

Results: Cucurbitacin compounds were detected in the n-hexane fraction at a concentration of 7.6 µg/mL per 10 mg of n-hexane fraction. MCF7 cell viability was lower than that of T47D cells across all concentrations tested. MCF7 cell viability was below 50% at a concentration of 62.5 µg/mL. In contrast, T47D cell viability remained at 100% even at the highest concentration of 125 µg/mL. The IC50 value of MCF7 cells was 43.5 µg/mL.

Conclusion: The cucurbitacin content in the n-Hexane fraction was 7.6 µg/mL per 10mg fraction. At this concentration, it moderately inhibits the proliferation of MCF7 cells.

Keywords: gama melon parfum, cucurbitacin, HPLC, T47D, MCF7


Full Text:

PDF

References


Benmeziane F, Djermoune-Arkoub L, Boudraa AT, Bellaagoune S. Physicochemical characteristics and phytochemical content of jam made from melon (Cucumis melo). Int Food Res J. 2018; 25(1): 133-41, article.

Maryanto SD, Ranis RE, Daryono BS. Stability phenotypic characters and the scent of gama melon parfum cultivar. JPS. 2015; 1(1):523-8, CrossRef.

Zhou Y, Ma Y, Zeng J, Duan L, Xue X, Wang H, et al. Convergence and divergence of bitterness biosynthesis and regulation in Cucurbitaceae. Nat Plants. 2016; 2: 16183, CrossRef.

Kaushik U, Aeri V, Mir SR. Cucurbitacins - An insight into medicinal leads from nature. Pharmacogn Rev. 2015; 9(17): 12-8, CrossRef.

Tosun E, Baysar A. Simultaneous isolation and purification of cucurbitacin D and I from Ecballium elaterium (l.) A. Rich fruit juice. Maced J Chem Chem Eng. 2019; 38(2): 171-82, CrossRef.

Salamah R, Widiyanto S. Chloroform fraction of Cucumis melo L. 'Gama Melon Parfum' Cytotoxicity against breast cancer cell T47D and MCF7. BIO Web Conf. 2022; 49: 02001, CrossRef.

Sinha S, Khan S, Shukla S, Lakra AD, Kumar S, Das G, et al. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis. Int J Biochem Cell Biol. 2016; 77(Pt A): 41-56, CrossRef.

Zubair MS, Alarif WM, Ghandourah MA, Anam S, Jantan I. Cytotoxic activity of 2-O-β-glucopyranosil cucurbitacin D from benalu batu (Begonia sp.) growing in Morowali, Central Sulawesi. Indones J Chem. 2020; 20(4): 766-72, CrossRef.

Yu S, Kim T, Yoo KH, Kang K. The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer. Biochem Biophys Res Commun. 2017; 486(3): 752-8, CrossRef.

Purwati DD, Mustika A, Hakim L, Thaha M. Correlation of serum nitric oxide and urine malondialdehyde levels in non-hemodialysis chronic kidney disease patients. Mol Cell Biomed Sci. 2022; 6(1): 43-9, CrossRef.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394-424, CrossRef.

Kadhim HM, Hamad MN, Kadhim YM. Cucurbita pepo L. var. pepo (Pumpkin) leaves extract. Int J Drug Deliv Technol. 2020; 10(3): 369-73, CrossRef.

Ul Haq F, Ali A, Khan MN, Shah SMZ, Kandel RC, Aziz N, et al. Metabolite profiling and quantitation of cucurbitacins in cucurbitaceae plants by liquid chromatography coupled to tandem mass spectrometry. Sci Rep. 2019; 9(1), CrossRef.

Mentari D, Pebrina R, Nurpratami D. Utilization of expired platelet concentrate for production of human platelet lysate as a medium for T47D cell propagation. Mol Cell Biomed Sci. 2022; 6(2): 96-103, CrossRef.

Alsayari A, Kopel L, Ahmed MS, Soliman HSM, Annadurai S, Halaweish FT. Isolation of anticancer constituents from Cucumis prophetarum var. prophetarum through bioassay-guided fractionation. BMC Complement Altern Med. 2018; 18(1): 274, CrossRef.

Abubakar AR, Haque M. Preparation of medicinal plants: Basic extraction and fractionation procedures for experimental purposes. J Pharm Bioallied Sci. 2020; 12(1): 1-10, CrossRef.

Kapoor N, Ghorai SM, Kushwaha PK, Shukla R, Aggarwal C, Bandichhor R. Plausible mechanisms explaining the role of cucurbitacins as potential therapeutic drugs against coronavirus 2019. Inform Med Unlocked. 2020; 21:100484, CrossRef.

Permatasari E, Farida, Widiyanto S. Cytotoxic effects and apoptosis of solo black garlic (Allium sativum L.) extract on T47D breast cancer cell Line. AIP Conf Proc. 2020; 2260(1): 060001-1-8, CrossRef.

Harris SL, Levine AJ. The p53 pathway: Positive and negative feedback loops. Oncogene. 2005; 24(17): 2899-908, CrossRef.

Hermawan A, Putri H, Fatimah N, Prasetio HH. Transcriptomics analysis reveals distinct mechanism of breast cancer stem cells regulation in mammospheres from MCF-7 and T47D cells. Heliyon. 2024; 10(2): e24356, CrossRef.




DOI: https://doi.org/10.21705/mcbs.v9i2.558

Copyright (c) 2025 Cell and BioPharmaceutical Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Indexed by:

               

             


Cell and BioPharmaceutical Institute